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Abstract
Background Handgrip strength (HGS) is used to identify individuals with low muscle strength (dynapenia). The inﬂuence of
the number of attempts on maximal HGS is not yet known and may differ depending on age and health status. This study
aimed to assess how many attempts of HGS are required to obtain maximal HGS.
Methods Three cohorts (939 individuals) differing in age and health status were included. HGS was assessed three times and
explored as continuous and dichotomous variable. Paired t-test, intraclass correlation coefﬁcients (ICC) and Bland–Altman
analysis were used to test reproducibility of HGS. The number of individuals with misclassiﬁed dynapenia at attempts 1 and
2 with respect to attempt 3 were assessed.
Results Results showed the same pattern in all three cohorts. Maximal HGS at attempts 1 and 2 was higher than at attempt 3 on
population level (P < 0.001 for all three cohorts). ICC values between all attempts were above 0.8, indicating moderate to high
reproducibility. Bland–Altman analysis showed that 41.0 to 58.9% of individuals had the highest HGS at attempt 2 and 12.4 to
37.2% at attempt 3. The percentage of individuals with amaximal HGS above the gender-speciﬁc cut-off value at attempt 3 compared
with attempts 1 and 2 ranged from 0 to 50.0%, with a higher percentage of misclassiﬁcation in middle-aged and older populations.
Conclusions Maximal HGS is dependent on the number of attempts, independent of age and health status. To assess
maximal HGS, at least three attempts are needed if HGS is considered to be a continuous variable. If HGS is considered as
a discrete variable to assess dynapenia, two attempts are sufﬁcient to assess dynapenia in younger populations. Misclassiﬁcation
should be taken into account in middle-aged and older populations.
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Introduction
Handgrip strength (HGS) is frequently measured as a proxy
for global muscle strength. Low muscle strength, also known
as dynapenia, is highly prevalent in old age.1 Approximately
25% of all 80 year olds have a HGS of more than 2.5 standard
deviations (SD) below the gender-speciﬁc peak mean of HGS
in a general population.2 Dynapenia is associated with
cognitive decline, impaired functional status and mortality,3
and is therefore an important indicator of health status.4 In
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addition, HGS is one of the diagnostic criteria for sarcopenia,
which is also highly prevalent in the older aged.5–7
A standardized protocol measuring maximal HGS is cur-
rently lacking, leading to considerable variation in assess-
ments.8,9 Most studies take between one and three
repeated measurements of HGS and report the maximal ef-
fort. The risk with taking too few measurements is that an in-
dividual may be misclassiﬁed as dynapenic. Few studies have
examined the inﬂuence of the number of attempts on maxi-
mal HGS; these have generally been performed in patients
with hand trauma10,11 or in healthy adults.12,13 In an older
community-dwelling population, one attempt was found to
be sufﬁcient to determine maximal HGS, which signiﬁcantly
decreased after more attempts.14 However, this result was
based on population level using intraclass correlation coefﬁ-
cients (ICC) and did not take individual variance into account.
Furthermore, the optimal number of HGS attempts may differ
depending on age, health status and on the use of HGS as a
discrete (cut-off value, mostly for clinical use) or continuous
variable (for research).
This study aimed to assess how many attempts of HGS are
required to obtain an optimal estimate of maximal HGS in
three cohorts: young and old healthy individuals from the
MyoAge cohort, middle-aged and old individuals from the
Grey Power cohort, and geriatric outpatients.
Methods
Study design
This study included three cross-sectional cohorts-based stud-
ies including 939 individuals with different age and health
status. This study has been performed in accordance with
the ethical standards laid down in the 1964 Declaration of
Helsinki.
MyoAge cohort
The European multicenter MyoAge study included healthy
young (n = 182, aged between 18 and 30 years) and old indi-
viduals (n = 322, aged between 69 and 81 years). Study ratio-
nale and design have been described in detail elsewhere.15
Exclusion criteria were aimed to ensure a selection of healthy
individuals free from major diseases: dependent living status,
inability to walk a distance of 250 m, morbidity (neurologic
disorders, metabolic diseases, rheumatic diseases, recent ma-
lignancy, heart failure, severe chronic obstructive pulmonary
disease and coagulation disorders), use of speciﬁc medication
(immunosuppressive drugs and insulin), immobilization for
one week during the previous 3 months and orthopaedic sur-
gery during the past 2 years or still causing pain or functional
limitation. Physical assessments were performed at local
study centers according to uniﬁed and standardized
operation procedures. For the present analyses, data from
the Netherlands (Leiden), Finland (Jyvaskyla), France (Paris)
and the UK (Manchester) were included. Data from Estonia
were excluded because HGS was only performed on the
right-hand side. Local medical ethical committees of the par-
ticipating medical centers approved the study, and all individ-
uals gave written informed consent.
Grey Power cohort
The Grey Power cohort included 256 community-dwelling
(aged between 20 and 91 years) individuals recruited from
the Grey Power debate events, which took place in
November 2014 at the VU University Medical Center,
Amsterdam, the Netherlands. The Grey Power debates were
freely accessible lectures for the general population to pro-
mote healthy ageing. Visitors were offered to participate in
the Grey Power study to test age-related and muscle-related
parameters and physical activity. No exclusion criteria were
applied. For the present analyses, the cohort was divided into
middle-aged individuals (n = 173) and old individuals (n = 89)
using a cut-off value of 70 years. Because of missing HGS
data, two middle-aged individuals and three old individuals
were excluded. This study was reviewed and approved by
the Medical Ethical Committee of the VU University Medical
Center (Amsterdam, the Netherlands). All individuals gave
written informed consent.
Geriatric outpatients
This cohort consisted of 299 geriatric outpatients (aged
between 48 and 97 years) who were consecutively referred
to a middle-sized teaching hospital (Bronovo Hospital, The
Hague, the Netherlands) between March 2011 and January
2012 for mobility problems. No exclusion criteria were ap-
plied; inclusion was based on referral. A comprehensive geri-
atric assessment (CGA) was performed by trained nurses and
medical staff, including questionnaires and measurements of
physical and cognitive performance. For the present analyses,
19 outpatients (6.4%) were excluded because of missing HGS
data. The need for individual informed consent was waived
by the Medical Ethical Committee of the Leiden University
Medical Center (Leiden, the Netherlands).
Characteristics of the different cohorts
Age, gender, presence of diseases and use of medication
were assessed by questionnaires in the MyoAge cohort and
Grey Power cohort and by medical charts in geriatric outpa-
tients. Living status was assessed in the MyoAge cohort and
in geriatric outpatients but not in the Grey Power cohort.
Independent living status was deﬁned as not living in an
assisted home or nursing home. In all cohorts, body weight
was assessed to the nearest 0.1 kg and height to the nearest
0.1 cm. Body composition was measured using dual-energy
X-ray absorptiometry in the MyoAge cohort (UK: Lunar
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Prodigy Advance, version EnCore 10.50.086; France: Lunar
Prodigy, version EnCore 12.30; the Netherlands: Hologic
QDR 4500, version 12.4; Finland: Lunar Prodigy, version
EnCore 9.30) and using direct segmental multi-frequency
bioelectrical impedance analysis (DSM-BIA) in the Grey
Power cohort (In-Body 230; Biospace Co., Ltd, Seoul, Korea)
and in geriatric outpatients (In-Body 720; Biospace Co., Ltd,
Seoul, Korea). DSM-BIA has been shown to be a reliable
measure for body composition compared with dual-energy
X-ray absorptiometry.16 In the geriatric outpatients, data on
body composition was available in 144 consecutive outpa-
tients because of a protocol amendment in which the DSM-
BIA was added at a later stage. Gait speed was assessed using
the 6 min walking test in the MyoAge cohort15 and using the
timed 4 m walking test in the Grey Power cohort and in geri-
atric outpatients. During the 4 m walking test, individuals
were asked to walk at normal pace from a standing start. Gait
speed was expressed in meters per second.
Assessment of handgrip strength
Handgrip strength was assessed three times on each hand al-
ternately using the Jamar hand-held hydraulic dynamometer
(Jamar hand dynamometer; Sammons Preston, Inc., Boling-
brook, IL, USA). Handle width was adjusted to hand size. Indi-
viduals were standing with their arms parallel to their trunk
and were encouraged to squeeze the dynamometer as hard
as possible. The following variables of HGS were used for
analysis: (i) maximal HGS at attempt 1, (ii) maximal HGS at at-
tempt 2, (iii) maximal HGS at attempts 1 and 2; and (iv) max-
imal HGS at attempt 3. Maximal HGS of the different
attempts were of either the right-hand or left-hand side. Re-
sults are not stratiﬁed by dominant hand because it is known
that maximal HGS is not always reached in the dominant
hand.17
Statistical analysis
Continuous variables with a Gaussian distribution were pre-
sented as mean (SD) and those with non-Gaussian distribu-
tion as median [interquartile range (IQR)]. A paired
Student’s t-test was performed to compare HGS between at-
tempt 1 vs. attempt 2, attempt 1 vs. attempt 3, attempt 2 vs.
attempt 3 and maximal HGS at attempts 1 and 2 vs. attempt
3. A two-tailed P-value of less than 0.05 was considered sta-
tistically signiﬁcant.
Single measure ICC were calculated to assess the reproduc-
ibility of HGS between attempt 1 vs. attempt 2, attempt 1 vs.
attempt 3, attempt 2 vs. attempt 3, maximal HGS at attempts
1 and 2 vs. attempt 3 and attempt 1 vs. maximal HGS at at-
tempts 1, 2 and 3. ICC values were calculated using a two-
way mixed model of absolute agreement.18 ICC values below
0.8 were considered insufﬁcient, values between 0.8 and 0.9
were considered moderate and values above 0.9 were con-
sidered high.19 Bland–Altman plots were used to assess the
reproducibility of HGS at the individual level.20 Mean differ-
ences were calculated with the 95% limits of agreement
(LOA) (mean difference  1.96 SD). The number of individ-
uals with a higher HGS at attempt 2 compared with attempt
1 was calculated and the number of individuals with a higher
HGS at attempt 3 compared with the maximal HGS at at-
tempts 1 and 2.
Finally, the inﬂuence of the number of attempts on the diag-
nosis of dynapenia was examined. Dynapenia was deﬁned using
gender-speciﬁc cut-off values; male < 30 kg, female < 20 kg.21
Misclassiﬁed as dynapenic was deﬁned as a maximal HGS
below the gender-speciﬁc cut-off value at attempts 1 and 2
but a HGS above the gender-speciﬁc cut-off value at attempt
3, dependent on the order of attempts. True-positives were
deﬁned as those classiﬁed as dynapenic at any of the 3
attempts, but above the gender-speciﬁc cut-off value on at
least one of the three attempts, independent on the order
of attempts.
Data were analysed using STATISTICAL PACKAGE FOR THE SOCIAL
SCIENCES, version 23 (SPSS Inc. Chicago, IL, USA). Visualization
was performed using GRAPHPAD PRISM 5.01.
Results
Characteristics of the different cohorts
Table 1 shows the characteristics of the three different
cohorts, stratiﬁed by age. The prevalence of multimorbidity
was higher in older age. Polypharmacy was more present in
geriatric outpatients compared with the other cohorts. Gait
speed and HGS were lower in geriatric outpatients compared
with the other cohorts. The majority of the individuals was
right-handed. Maximal HGS was reached by the dominant
hand in 59.6 to 79.9% of the individuals.
Reproducibility at population level in three cohorts
Handgrip strength at attempt 1was higher than at attempt 2 in
healthy old individuals from theMyoAge cohort (P< 0.01) and
not statistically signiﬁcant higher in the other cohorts. Maxi-
mal HGS at attempts 1 and 2 was higher than the HGS at at-
tempt 3 in all cohorts: on average, 1.5 kg in healthy young
individuals and 0.6 kg in healthy old individuals (MyoAge co-
hort), 1.3 kg in middle-aged individuals and 1.1 kg in old indi-
viduals (Grey Power cohort), and 0.9 kg in geriatric
outpatients (P< 0.001 for all cohorts). Supporting Information
Figure S1 shows maximal HGS of either the right-hand or left-
hand side of the three cohorts on population level, stratiﬁed
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by age. Stratiﬁcation by hand side showed the same results as
the total group (Supporting Information Figure S2).
Table 2 shows ICC values and the mean differences with
the 95% LOA between maximal HGS of different attempts,
stratiﬁed by cohort and age. ICC values between all attempts
were above 0.8 or 0.9, indicating moderate to high reproduc-
ibility. In all cohorts, the 95% LOA of maximal HGS at at-
tempts 1 and 2 vs. attempt 3 were higher than the 95%
LOA between attempt 1 vs. attempt 2, attempt 1 vs. attempt
3, attempt 2 vs. attempt 3 and attempt 1 vs. maximal HGS at
attempts 1, 2 and 3. ICC values and the mean differences
with the 95% LOA stratiﬁed by hand side showed the same
results as when analysed as a total group (Supporting
Information Table S1).
Reproducibility at individual level in three cohorts
Figure 1 shows Bland–Altman plots of HGS at attempt 1 vs.
attempt 2. Figure 2 shows Bland–Altman plots of HGS at
Table 1 Characteristics of the three cohorts, stratiﬁed by age
MyoAge cohort Grey Power cohort
Geriatric outpatients
Healthy young Healthy old Middle-aged Old
n = 139 n = 258 n = 173 n = 89 n = 280
Sociodemographics
Age, years, median [IQR] 22.9 [21.0–25.4] 73.7 [71.7–77.1] 62.6 [52.9–66.7] 74.5 [72.5–78.1] 82.8 [78.3–87.2]
Male, n (%) 67 (48.2) 130 (50.4) 55 (31.8) 34 (38.2) 96 (34.3)
Independent living, n (%) 139 (100) 258 (100) n/a n/a 227 (82.2)
Health characteristics
Multimorbiditya, n (%) 0 38 (14.7) 15 (8.7) 20 (22.5) 94 (35.5)
Polypharmacyb, n (%) 0 22 (8.5) 4 (2.3) 10 (11.4) 151 (56.1)
Body composition
BMI, kg/m2 22.8 (3.0) 25.4 (3.3) 25.1 (3.7) 26.2 (3.8) 25.9 (4.5)
Fat mass, % 23.1 (9.4) 30.4 (8.1) 28.3 (8.5) 32.5 (8.0) 30.5 (10.8)
Physical performance
Gait speed, m/s 1.85 (0.33) 1.50 (0.22) 1.46 (0.20) 1.39 (0.21) 0.73 (0.27)
Handgrip strength, kg
Males 52.8 (10.0) 40.4 (7.7) 48.4 (10.1) 38.7 (9.5) 33.5 (6.4)
Females 33.7 (4.9) 25.9 (5.0) 31.8 (6.4) 27.0 (6.1) 21.0 (4.9)
Hand dominance
Right-handed, n (%) 81 (89.0)c 159 (97.0)d 151 (87.3) 83 (93.3) 249 (90.5)e
Max. HGSdominant
f, n (%) 68 (74.7)c 131 (79.9)d 123 (71.1) 53 (59.6) 164 (59.6)e
All values are presented as mean (SD) unless indicated otherwise. IQR, interquartile range, BMI, body mass index; HGS, handgrip strength.
aDeﬁned as ≥2 diseases including: MyoAge cohort—hypertension, cardiovascular events, noninsulin-dependent diabetes mellitus, mild
chronic obstructive pulmonary disease (COPD), osteoarthritis, arterial surgery and thyroid disease; Grey Power cohort and geriatric outpa-
tients—hypertension, myocardial infarction, stroke, diabetes mellitus, COPD, cancer, Parkinson’s disease and rheumatoid arthritis/
osteoarthritis.
bDeﬁned as ≥5 medicaments.
Data available in a subgroup of
cn = 91,
dn = 164,
en = 275.
fMaximal HGS reached by the dominant hand.
Table 2 Intraclass correlation coefﬁcients and mean differences between maximal handgrip strength, stratiﬁed by cohort and age
MyoAge cohort Grey Power cohort
Geriatric outpatients
Healthy young Healthy old Middle-aged Old
n = 139 n = 258 n = 173 n = 89 n = 280
ICC (95% CI)
Attempt 1 vs. 2 0.96 (0.95–0.97) 0.97 (0.96–0.98) 0.95 (0.94–0.97) 0.96 (0.94–0.98) 0.94 (0.93–0.96)
Attempt 1 vs. 3 0.95 (0.93–0.96) 0.96 (0.95–0.97) 0.95 (0.93–0.96) 0.97 (0.95–0.98) 0.94 (0.92–0.95)
Attempt 2 vs. 3 0.97 (0.96–0.98) 0.98 (0.97–0.98) 0.96 (0.95–0.97) 0.98 (0.96–0.98) 0.97 (0.96–0.98)
Attempt 1, 2 vs. 3 0.96 (0.92–0.98) 0.97 (0.97–0.98) 0.95 (0.92–0.97) 0.97 (0.93–0.99) 0.95 (0.92–0.97)
Attempt 1 vs. 1, 2, 3 0.98 (0.90–0.99) 0.97 (0.82–0.99) 0.96 (0.87–0.98) 0.97 (0.90–0.99 0.96 (0.82–0.98)
Mean difference (95% LOA)
Attempt 1 vs. 2 0.30 (6.37–6.97) 0.52 (5.23–4.20) 0.03 (6.41–6.36) 0.21 (5.26–4.83) 0.29 (5.41–4.84)
Attempt 1 vs. 3 0.39 (6.99–7.76) 0.59 (5.73–4.54) 0.12 (6.73–6.97) 0.04 (4.52–4.61) 0.16 (5.67–5.36)
Attempt 2 vs. 3 0.09 (6.03–6.21) 0.08 (4.14–3.98) 0.15 (5.37–5.67) 0.26 (3.77–4.29) 0.13 (3.79–4.05)
Attempt 1, 2 vs. 3 1.52 (4.65–7.68) 0.60 (3.55–4.75) 1.32 (4.87–7.50) 1.10 (2.48–4.69) 0.92 (3.59–5.43)
Attempt 1 vs. 1, 2, 3 1.66 (5.82–2.50) 1.70 (5.35–1.94) 1.75 (6.33–2.84) 1.35 (4.95–2.25) 1.50 (5.09–2.09)
ICC, intraclass correlation coefﬁcient; CI, conﬁdence interval; LOA, limits of agreement.
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attempts 1 and 2 vs. attempt 3. Supporting Information Figure
S3 shows Bland–Altman plots of HGS at attempt 1 vs. maximal
HGS at attempts 1, 2 and 3. It shows that a considerable
number of individuals did not reach maximal HGS at attempt
1: MyoAge cohort healthy young individuals 60.4, healthy
old individuals 70.9; Grey Power cohort middle-aged individ-
uals 52.0, old individuals 49.4; geriatric outpatients 57.1%.
Table 3 shows the number of individuals classiﬁed as
dynapenic assessed at different attempts, stratiﬁed by cohort
and age. The percentage of individuals with a maximal HGS
above the gender-speciﬁc cut-off value at attempt 3 com-
pared with attempts 1 and 2 ranged from 0 to 50% with
higher values in middle-aged and older populations and
therewith higher dynapenia misclassiﬁcation in populations
with higher age. The percentage of true-positives was higher
using three attempts compared with using two attempts in all
three populations.
MyoAge cohort
In healthy young individuals, a higher HGS of on average
2.3 kg (SD 1.9) at attempt 2 was found in 67 (48.2%) individ-
uals compared with attempt 1. A higher HGS at attempt 3
compared with the maximal HGS at attempts 1 and 2 was
found in 41 (29.5%) individuals with an average of 1.8 kg
(SD 1.7). None of the healthy young individuals were classi-
ﬁed as dynapenic using the maximal HGS at attempts 1, 2
and 3 dependent on the order of attempts.
In healthy old individuals, a higher HGS of on average
2.0 kg (SD 1.6) at attempt 2 was found in 152 (58.9%) individ-
uals compared with attempt 1. A higher HGS at attempt 3
compared with the maximal HGS at attempts 1 and 2 was
found in 96 (37.2%) individuals with an average of 1.4 kg
(SD 1.0). Using the maximal HGS at attempts 1 and 2, 23
(8.9%), individuals were classiﬁed as dynapenic of which 4
(17.4%) had a maximal HGS above the gender-speciﬁc cut-
Figure 1 Bland–Altman plots of handgrip strength at attempt 1 vs. attempt 2. Results are stratiﬁed by cohort and age: MyoAge cohort ((A) healthy
young, (B) healthy old), Grey Power cohort ((C) middle-aged, (D) old) and geriatric outpatients (E). The dashed lines represent the mean difference
in handgrip strength with the upper and lower 95% limits of agreement (mean difference  1.96 SD). Grey dots represent males and black dots
represent females. Δ = difference.
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Figure 2 Bland–Altman plots of handgrip strength of maximal handgrip strength at attempt 1 or attempt 2 vs. attempt 3. Results are stratiﬁed by co-
hort and age: MyoAge cohort ((A) healthy young, (B) healthy old), Grey Power cohort ((C) middle-aged, (D) old) and geriatric ooutpatients (E). The
dashed lines represent the mean difference in handgrip strength with the upper and lower 95% limits of agreement (mean difference  1.96 SD). Grey
dots represent males and black dots represent females. Δ = difference.
Table 3 Number of individuals classiﬁed as dynapenic dependent on the number of attempts, stratiﬁed by cohort and age
MyoAge cohort Grey Power cohort
Geriatric outpatients
Healthy young Healthy old Middle-aged Old
n = 139 n = 258 n = 173 n = 89 n = 280
Dynapenia in order of attempts
Attempt 1 0 39 (15.1) 7 (4.0) 12 (13.5) 122 (43.6)
Attempt 1 and 2 0 23 (8.9) 6 (3.5) 10 (11.2) 99 (35.4)
Attempt 1, 2 and 3 0 19 (7.4) 3 (1.7) 10 (11.2) 88 (31.4)
True–positivesa
Attempt 1 and 2 2 (1.4) 25 (9.7) 3 (1.7) 4 (4.5) 31 (11.1)
Attempt 1, 2 and 3 3 (2.2) 34 (13.2) 6 (3.5) 7 (7.9) 51 (18.2)
All variables are presented as n (%).
Dynapenia was deﬁned using gender speciﬁc cut–off values; males <30 kg, females <20 kg.
aTrue–positive deﬁned as those classiﬁed as dynapenic at any of the 3 attempts, but above the gender speciﬁc cut–off value on at least
one of the three attempts, independent on the order of attempts
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off value at attempt 3, which was higher compared with
attempts 1 and 2 and would therewith be misclassiﬁed as
dynapenic by use of 2 attempts.
Grey Power cohort
In middle-aged individuals, a higher HGS of on average 2.9 kg
(SD 1.7) at attempt 2 was found in 71 (41.0%) individuals
compared with attempt 1. A higher HGS at attempt 3 com-
pared with the maximal HGS at attempts 1 and 2 was found
in 35 (20.2%) individuals with an average of 2.7 kg (SD 2.2)
higher HGS. Using the maximal HGS at attempts 1 and 2, 6
(3.5%), individuals were classiﬁed as dynapenic of which 3
(50.0%) had a maximal HGS above the gender-speciﬁc cut-
off value at attempt 3, which was higher compared with
attempts 1 and 2 and would therewith be misclassiﬁed as
dynapenic by use of 2 attempts.
In old individuals, a higher HGS of on average 2.5 kg (SD 1.6)
was found in 38 (42.6%) individuals compared with attempt 1.
A higher HGS at attempt 3 compared with the maximal HGS at
attempts 1 and 2 was found in 11 (12.4%) individuals with an
average of 1.6 kg (SD 0.5) higher HGS. Using the maximal
HGS at attempts 1 and 2, 10 (11.2%) individuals were classiﬁed
as dynapenic of which 1 (10.0%) had a maximal HGS above the
gender-speciﬁc cut-off value at attempt 3, which was higher
compared with attempts 1 and 2 and would therewith be
misclassiﬁed as dynapenic by use of 2 attempts.
Geriatric outpatients
A higher HGS of on average 2.4 kg (SD 1.7) at attempt 2 was
found in 124 (44.3%) individuals compared with attempt 1. A
higher HGS at attempt 3 compared with the maximal HGS at
attempt 1 and 2 was found in 69 (24.6%) individuals with an
average of 1.7 kg (SD 0.9). Using the maximal HGS at
attempts 1 and 2, 99 (35.4%) individuals were classiﬁed as
dynapenic of which 11 (11.1%) had a maximal HGS above
the gender-speciﬁc cut-off value at attempt 3, which was
higher compared with attempts 1 and 2 and would therewith
be misclassiﬁed as dynapenic by use of 2 attempts.
Summary of results
On population level, maximal HGS at attempts 1 and 2 was
signiﬁcantly higher than attempt 3. On individual level, 12.4
to 37.2% of the individuals reached the highest HGS at
attempt 3 compared with the maximal HGS at attempts 1
and 2 with an average of 1.4 kg to 2.7 kg higher HGS.
Discussion
Maximal HGSwas found to be dependent on the number of at-
tempts in all three cohorts. At least three attempts are needed
if HGS is considered as a continuous variable. If HGS is used as
a discrete value with a cut-off value to assess dynapenia, the
percentage of individuals misclassiﬁed as dynapenic by use
of two attempts compared with the use of three attempts
was higher in middle-aged and older populations.
Maximal HGS at attempts 1 and 2 was signiﬁcantly higher
on population level than attempt 3 in all three cohorts. De-
spite the moderate to high ICC values, a signiﬁcant number
of individuals had a higher HGS at attempts 2 and attempt
3 compared with attempt 1. Previous studies yielded con-
trasting results on how many attempts of HGS should be
assessed to obtain maximal HGS.10–14 Some studies con-
cluded that one attempt should be sufﬁcient because ICC
values between the efforts were high10–12,14 and maximal
HGS decreased signiﬁcantly at attempts 2 and 314 or a signif-
icant increase in pain was seen after several HGS attempts.11
In contrast, we conclude that one attempt is insufﬁcient be-
cause approximately half of the individuals had a higher
HGS at attempt 2 compared with attempt 1. One previous
study has concluded that three attempts are needed because
this gave the highest test–retest reliability assessed with
Pearson product moment correlation coefﬁcient analysis.13
Some of these previous studies were performed in individuals
with hand trauma on the affected side9,10 that represent a
particular participant group and thus the results may not be
generalizable to the wider older population. Two of the pre-
vious mono-centre studies were performed in healthy indi-
viduals12,13 but included only limited number of individuals
(n = 33 and n = 27, respectively). A limitation of all aforemen-
tioned studies10–14 is that Bland–Altman analysis was not per-
formed; consequently, the variance at the individual level was
not analysed. It can therefore not be ruled out that in the
previous studies, a similar number of individuals did obtain
the highest HGS at attempt 3.
The number of attempts to assess HGS depends on the goal
that is pursued. If an underestimation of the HGS value is un-
desirable and HGS is considered as a continuous variable, we
recommend to measure HGS at least three times to avoid un-
derestimation of HGS. This underestimation is relevant as a re-
cent meta-analysis showed a signiﬁcant association of even
1 kg difference in grip strength andmortality in older cohorts.3
One of the strengths of this study is that HGS was tested in
different cohorts thereby making the results generalizable to
populations differing in age and health status. Another
strength is the fact that HGS was analysed both as a continu-
ous value and as a discrete variable. Pain during the assess-
ment of HGS was not registered, which forms a limitation
of the study. Another limitation is that it cannot be excluded
whether individuals would reach an even higher maximal
HGS after more than 3 attempts.
Conclusions
Maximal HGS is dependent on the number of attempts, in-
dependent of age and health status. If HGS is considered as
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a continuous variable, HGS should be performed three
times. The percentage of individuals misclassiﬁed as
dynapenic by use of two attempts is higher in middle-aged
and older populations compared with younger populations.
If HGS is considered as a discrete variable to assess
dynapenia, two attempts are sufﬁcient in younger popula-
tions; in middle-aged and older populations, the percentage
of misclassiﬁcation should be taken into account when using
two attempts. Future research should focus on other aspects
of standardization of the assessment of HGS such as the
inﬂuence of pain, posture and hand dominance. In addition,
other reproducibility such as day-to-day or month-to-month
variation should be assessed in a longitudinal design.
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